World's leading clinical conference on bone, joint and muscle health
Programme
Saturday April 18th - CEST Timezone
08:00 - 09:00
Non-Sponsored Symposia
08:00
MR - D9
Update in Musculoskeletal Conditions with Hand Involvement
Chairpersons: Fitnat Dincer, Andreas Winkelmann
Chairpersons: Fitnat Dincer, Andreas Winkelmann
08:00
MR - D9
Update in Degenerative joint disease of Hand, Osteoarthritic Hand
08:00
MR - D9
Update in Soft tissue lesions /non articular involvement of Hand
08:00
MR - D8
Music, Rhythm, Music, and Cognition: Implementing Dalcroze Eurhythmics to Preserve Capacity in Care Home Residents
Chairpersons: Yasser El Miedany, Naglaa Gadallah
Chairpersons: Yasser El Miedany, Naglaa Gadallah
08:00
MR - D8
The Neurological Symphony: Rhythmic Auditory-Motor Coupling and Dual-Task Training Effects of Eurhythmics on Balance and Executive Function
08:00
MR - D8
"The Moving Body": Developing a Scalable and Safe Dalcroze Protocol for Older Adults with Varying Cognitive and Physical Limitations in Residential Care
08:00
MR - D8
Beyond Falls: Assessing the Impact of Dalcroze Eurhythmics on Quality of Life, Social Engagement, and Care Home Service Cost-Effectiveness
08:00
MR - D1
Muscle impairment in patients with rheumatic diseases: A pragmatic approach
Chairpersons: Osvaldo Daniel Messina, Jorge Luis Alberto Morales-Torres
Chairpersons: Osvaldo Daniel Messina, Jorge Luis Alberto Morales-Torres
08:00
MR - D1
Introduction: the need for pragmatic approaches for patients at risk.
08:00
MR - D1
Muscle impairment: the problem with outcomes
08:00
MR - D1
Muscle impairment: adapting diagnosis to joint limitations
08:00
MR - D1
Muscle impairment: primary and secondary prevention today
08:00
MR - D1
Discussion and conclusions
08:00
MR - D2
Multimorbidity and Fracture Outcomes
Chairpersons: Jacqueline R. Center, Robert D. Blank
Chairpersons: Jacqueline R. Center, Robert D. Blank
08:00
MR - D2
Multimorbidity contribues to the osteoporosis treatment gap.
08:00
MR - D2
Multimorbidity double burden: Elevated fracture risk despite high mortality following fracture.
08:00
MR - D2
Risk stratification for imminent subsequent fractures: A DeepHit approach using administrative health data.
08:00
MR- D4
Low-dose Radiotherapy in Musculoskeletal Disorders: Emerging Strategies for Pain Management and Inflammatory Modulation
Chairperson: África Fernández Forné
Chairperson: África Fernández Forné
08:00
MR- D4
Low-dose radiotherapy in degenerative musculoskeletal disorders: From radiobiological principles to clinical practice.
08:00
MR- D4
Beyond conventional therapies: A rheumatologist’s perspective on the management of complex and refractory patients.
08:00
MR- D4
Building clinical evidence: Preliminary results from the FINGERT and TROCANTERT studies
08:00
MR- D4
Discussion and Q&A
08:00
MR - D7
Emphasizing the importance of osteoporotic vertebral fractures: focus on diagnosis and care.
Chairperson: Anabela Barcelos
Chairperson: Anabela Barcelos
08:00
MR - D7
Early Detection of Vertebral Fragility Fractures: Bridging the Diagnostic Gap
08:00
MR - D7
Opportunistic diagnosis of vertebral fractures using routine CT-scans: the Portuguese experience and literature review
08:00
MR - D7
Assessing Quality of Life After Vertebral Fracture: The Value of the Portuguese-Validated QUALEFFO-41 Over Generic Instruments
08:00
MR - D7
Closing remarks
08:00 - 09:00
Auditorium 1
Sponsored Satellite Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
08:00 - 09:00
Auditorium 2
Sponsored Breakfast Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
08:00 - 09:00
MR - D12
WFS-IOF-ESCEO Joint Symposium:Fracture Prevention in Older Adults
Chairpersons: Tahir Masud, Nicholas Harvey
Chairpersons: Tahir Masud, Nicholas Harvey
08:00
MR - D12
Pharmacological treatments for osteoporosis in the oldest older persons
08:20
MR - D12
The interplay between osteoporosis, dementia and fragility fractures
08:40
MR - D12
Reducing falls and fractures by medication optimisation
09:00 - 10:30
Auditorium 1
Scientific Session IV
Chairpersons: Fitnat Dincer, Vladimir Palicka
Chairpersons: Fitnat Dincer, Vladimir Palicka
09:00
Auditorium 1
Plenary Lecture
En route to a global sarcopenia consensus
En route to a global sarcopenia consensus
09:30
Auditorium 1
Oral communications selected from abstracts
OC19 - HIGH MORTALITY IN OLDER MEN WITH LOW MUSCLE MASS AND STRENGTH – THE PROSPECTIVE STRAMBO STUDY
OC19 - HIGH MORTALITY IN OLDER MEN WITH LOW MUSCLE MASS AND STRENGTH – THE PROSPECTIVE STRAMBO STUDY
09:40
Auditorium 1
Oral communications selected from abstracts
OC20 - LOWER INTRINSIC CAPACITY AND SARCOPENIA: DATA FROM THE GEELONG OSTEOPOROSIS STUDY
OC20 - LOWER INTRINSIC CAPACITY AND SARCOPENIA: DATA FROM THE GEELONG OSTEOPOROSIS STUDY
09:50
Auditorium 1
Oral communications selected from abstracts
OC21 - INCREASED DIETARY FIBER INTAKE IS ASSOCIATED WITH BETTER GRIP STRENGTH AND PHYSICAL PERFORMANCE IN COMMUNITY-DWELLING OLDER ADULTS
OC21 - INCREASED DIETARY FIBER INTAKE IS ASSOCIATED WITH BETTER GRIP STRENGTH AND PHYSICAL PERFORMANCE IN COMMUNITY-DWELLING OLDER ADULTS
10:00
Auditorium 1
Oral communications selected from abstracts
OC22 - EFFECT OF DALCROZE EURHYTHMICS EXERCISE ON MUSCLE, PHYSICAL AND COGNITIVE FUNCTION, AND FALLS IN SARCOPENIC OLDER ADULTS: THE SARCARE RANDOMIZED CONTROLLED TRIAL
OC22 - EFFECT OF DALCROZE EURHYTHMICS EXERCISE ON MUSCLE, PHYSICAL AND COGNITIVE FUNCTION, AND FALLS IN SARCOPENIC OLDER ADULTS: THE SARCARE RANDOMIZED CONTROLLED TRIAL
10:10
Auditorium 1
Oral communications selected from abstracts
OC23 - IDENTIFICATION OF FACTORS ASSOCIATED WITH NON-RESPONSE TO A MULTICOMPONENT INTERVENTION IN OLDER ADULTS WITH PHYSICAL FRAILTY AND SARCOPENIA
OC23 - IDENTIFICATION OF FACTORS ASSOCIATED WITH NON-RESPONSE TO A MULTICOMPONENT INTERVENTION IN OLDER ADULTS WITH PHYSICAL FRAILTY AND SARCOPENIA
10:20
Auditorium 1
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
10:30 - 12:15
Auditorium 1
Scientific Session V
Chairpersons: Manju Chandran, Karel Pavelka
Chairpersons: Manju Chandran, Karel Pavelka
10:30
Auditorium 1
Presentation of the IOF Olof Johnell Science Award
10:35
Auditorium 1
Presentation of the ESCEO-IOF Young Investigator Awards
10:40
Auditorium 1
Presentation of the ESCEO-Aging Clinical and Experimental Research Award
10:45
Auditorium 1
Plenary Lecture
Nutritional strategies for optimal muscle health
Nutritional strategies for optimal muscle health
11:15
Auditorium 1
Oral communications selected from abstracts
OC24 - CAN AI-DERIVED BMD FROM ROUTINE RADIOGRAPHS PREDICT FRACTURE RISK? A 6-YEAR FOLLOW-UP STUDY
OC24 - CAN AI-DERIVED BMD FROM ROUTINE RADIOGRAPHS PREDICT FRACTURE RISK? A 6-YEAR FOLLOW-UP STUDY
11:25
Auditorium 1
Oral communications selected from abstracts
OC25 - FOREARM BMD IS A FRAX INDEPENDENT PREDICTOR OF FRACTURE RISK
OC25 - FOREARM BMD IS A FRAX INDEPENDENT PREDICTOR OF FRACTURE RISK
11:35
Auditorium 1
Oral communications selected from abstracts
OC26 - PREDICTION OF INCIDENT FRACTURES USING THE AI-BASED TBS REVEAL BONE FRAGILITY INDEX: A BAYESIAN SURVIVAL ANALYSIS
OC26 - PREDICTION OF INCIDENT FRACTURES USING THE AI-BASED TBS REVEAL BONE FRAGILITY INDEX: A BAYESIAN SURVIVAL ANALYSIS
11:45
Auditorium 1
Oral communications selected from abstracts
OC27 - 3D-SHAPER DIFFERENTIATION OF CORTICAL AND TRABECULAR BONE DESCRIBES FRACTURE STATUS IN PATIENTS WITH KIDNEY DISEASE
OC27 - 3D-SHAPER DIFFERENTIATION OF CORTICAL AND TRABECULAR BONE DESCRIBES FRACTURE STATUS IN PATIENTS WITH KIDNEY DISEASE
11:55
Auditorium 1
Oral communications selected from abstracts
OC28 - PERFORMANCE OF NOGG GUIDELINES BASED ON FRAX PRIOR TO DXA VS FRAX CALCULATED USING A FEMORAL NECK ESTIMATE FROM AN OPPORTUNISTIC SCREEN OF LOW BONE DENSITY FROM STANDARD X-RAY
OC28 - PERFORMANCE OF NOGG GUIDELINES BASED ON FRAX PRIOR TO DXA VS FRAX CALCULATED USING A FEMORAL NECK ESTIMATE FROM AN OPPORTUNISTIC SCREEN OF LOW BONE DENSITY FROM STANDARD X-RAY
12:05
Auditorium 1
Oral communications selected from abstracts
OC29 - SUPERIOR FRAGILITY FRACTURE DISCRIMINATION BY CORTICAL ULTRASOUND SPECTROSCOPY COMPARED WITH BONE MINERAL DENSITY IN WOMEN AND MEN
OC29 - SUPERIOR FRAGILITY FRACTURE DISCRIMINATION BY CORTICAL ULTRASOUND SPECTROSCOPY COMPARED WITH BONE MINERAL DENSITY IN WOMEN AND MEN
12:15 - 13:45
Auditorium 1
Sponsored Satellite Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
12:15 - 13:45
Auditorium 2
Sponsored Satellite Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
14:00 - 15:00
Meet-The-Expert Session
14:00
MR - D9
Screening for high fracture risk
14:00
MR - D8
Rare bone diseases for the osteoporosis physician
14:00
MR - D1
Meta-analysis: makings sense of umbrella and network approaches
14:00
MR - D2
Exercise: what to recommend in osteoporosis
14:00 - 15:00
Podium
Oral presentations of selected posters
Chairperson: Elaine Dennison
Chairperson: Elaine Dennison
14:00
Podium
OP12 - P1094 - WHAT PROPORTION OF WOMEN EXPERIENCE SIGNIFICANT TRANSMENOPAUSAL BONE LOSS?
14:06
Podium
OP13 - P1496 - APPLICATION OF MACHINE LEARNING MODELS FOR OSTEOPOROSIS SCREENING: BUSHEHR ELDERLY HEALTH (BEH) PROGRAM
14:12
Podium
OP14 - P1702 - HOW COMMON IS IT? HIGH AND VERY HIGH-RISK FRACTURE RATES AMONG PATIENTS WITH A NON-OSTEOPOROTIC-RANGE BONE MINERAL DENSITY IN A DXA DATABASE FROM A TERTIARY MEDICAL CENTER
14:18
Podium
OP15 - P807 - SERUM PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) AND BONE MINERAL DENSITY IN NORWEGIAN ADOLESCENTS: SEX-SPECIFIC ASSOCIATIONS AND MIXTURE EFFECTS
14:24
Podium
OP16 - P1370 - MATERNAL DIABETES IN PREGNANCY AND FRACTURE RISK IN OFFSPRING: A VICTORIA STATE-WIDE DATA LINKAGE STUDY
14:30
Podium
OP17 - P527 - SEX- AND DISTRIBUTION-SPECIFIC PROSPECTIVE MUSCLE-FAT-FRACTURE RELATIONSHIPS IN UK BIOBANK
14:36
Podium
OP18 - P735 - THE LANDSCAPE OF RENAL OSTEODYSTROPHY IN EUROPE: A FIRST REPORT FROM THE EUROD BONE BIOPSY DATABASE
14:42
Podium
OP19 - P1437 - LONG-TERM QUALITY OF LIFE TRAJECTORIES IN FIBROUS DYSPLASIA AND MCCUNE-ALBRIGHT SYNDROME
14:48
Podium
OP20 - P500 - IMPAIRED ORAL HEALTH PREDICTS FRACTURES AND FALLS IN OLDER ADULTS: A PROSPECTIVE COHORT STUDY
14:54
Podium
OP21 - P849 - THE SINTER STUDY: A RECALL-BY-GENOTYPE DESIGN WITH MULTIDIMENSIONAL MUSCULOSKELETAL PHENOTYPING ACROSS INTERNAL-MEDICINE OUTPATIENT CLINICS
15:00
Podium
OP22 - P586 - DEVELOPMENT AND EXPERT VALIDATION OF AN INTERNATIONAL POSTMENOPAUSAL OSTEOPOROSIS RISK ASSESSMENT AND LIFESTYLE (IPORL) QUESTIONNAIRE
15:06
Podium
OP23 - P386 - FRACTURES AND BONE MINERAL DENSITY LOSS IN ADULTS LIVING WITH HIV IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW AND META-ANALYSIS
14:00 - 15:00
MR- D4
Educational Lecture: CKD-Associated Osteoporosis: The Overlooked Burden of Bone Fragility in CKD
Chairperson: Maria Fusaro
Chairperson: Maria Fusaro
14:00
MR- D4
Denosumab use in advanced CKD patients: yes or no, this is the dilemma
14:00
MR- D4
Mendelian randomization role of vitamin D in coronary heart disease
14:00
MR- D4
Bone quality in CKD: How to assess and why it matters
14:00
MR- D4
KIDNEY-FRAX®: Is it the right time to perform it?
14:00 - 15:00
MR - D3
OARSI-ESCEO Symposium: Obesity and its implications for pain and structure in osteoarthritis
Chairpersons: Martin Englund, Jean-Yves Reginster
Chairpersons: Martin Englund, Jean-Yves Reginster
14:00
MR - D3
The role of obesity and adipose tissue dysfunction in osteoarthritis pain
14:00
MR - D3
Structural changes with weight loss in knee osteoarthritis
14:00 - 15:00
MR - D12
EuGMS-IOF-ESCEO Joint Symposium: Integrating falls and fractures management in the patient-centered care
Chairpersons: Nathalie Van der Velde, Carmelinda Ruggiero, René Rizzoli
Chairpersons: Nathalie Van der Velde, Carmelinda Ruggiero, René Rizzoli
14:00
MR - D12
Landscape for integrated falls and fragility fracture pathways across Europe: where do we stand?
14:00
MR - D12
Falls and fragility fractures in older adults with neurocognitive disorders: preparing for the impending storm
14:00
MR - D12
Integrating falls and fragility fractures secondary prevention: the small win of the orthogeriatric care pathway
15:00 - 16:45
MR - D12
Committee of Scientific Advisors Special Session:
Chairpersons: Eugene McCloskey, Etienne Cavalier
Chairpersons: Eugene McCloskey, Etienne Cavalier
15:00 - 17:00
Auditorium 1
Scientific Session VI
Chairpersons: Claudia Campusano, Atsushi Suzuki
Chairpersons: Claudia Campusano, Atsushi Suzuki
15:00
Auditorium 1
Plenary Lecture
State of the art: advances in osteoarthritis imaging
State of the art: advances in osteoarthritis imaging
15:30
Auditorium 1
Oral communications selected from abstracts
OC30 - INFRAPATELLAR FAT PAD MORPHOLOGY AND SIGNAL PREDICTS KNEE REPLACEMENT RISK IN OSTEOARTHRITIS: AN 8-YEAR MRI CASE-CONTROL STUDY
OC30 - INFRAPATELLAR FAT PAD MORPHOLOGY AND SIGNAL PREDICTS KNEE REPLACEMENT RISK IN OSTEOARTHRITIS: AN 8-YEAR MRI CASE-CONTROL STUDY
15:40
Auditorium 1
Oral communications selected from abstracts
OC31 - QUANTIFYING TREATMENT-RELATED INFLAMMATORY CHANGE IN KNEE OSTEOARTHRITIS USING NORMALIZED MRI INFLAMMATION VOLUME (NORMI)
OC31 - QUANTIFYING TREATMENT-RELATED INFLAMMATORY CHANGE IN KNEE OSTEOARTHRITIS USING NORMALIZED MRI INFLAMMATION VOLUME (NORMI)
15:50
Auditorium 1
Oral communications selected from abstracts
OC32 - FROM MODEL TO APPLICATION: METABOLOMIC-DRIVEN MACHINE LEARNING FOR PROGNOSIS OF KNEE STRUCTURAL OSTEOARTHRITIS PROGRESSION
OC32 - FROM MODEL TO APPLICATION: METABOLOMIC-DRIVEN MACHINE LEARNING FOR PROGNOSIS OF KNEE STRUCTURAL OSTEOARTHRITIS PROGRESSION
16:00
Auditorium 1
Oral communications selected from abstracts
OC33 - TOWARDS OA PATIENTS ENDOTYPING : DEVELOPMENT OF AN LC-MS/MS METHOD FOR THE QUANTITATION OF JOINT-RELATED COLLAGENS FRAGMENTS
OC33 - TOWARDS OA PATIENTS ENDOTYPING : DEVELOPMENT OF AN LC-MS/MS METHOD FOR THE QUANTITATION OF JOINT-RELATED COLLAGENS FRAGMENTS
16:10
Auditorium 1
Oral communications selected from abstracts
OC34 - Intra-articular polyacrylamide hydrogel for knee osteoarthritis: 1-year results from the LUNA observational study.
OC34 - Intra-articular polyacrylamide hydrogel for knee osteoarthritis: 1-year results from the LUNA observational study.
16:20
Auditorium 1
Oral communications selected from abstracts
OC35 - Expert consensus on hyaluronic acid injections for knee osteoarthritis: a patient-centered approach
OC35 - Expert consensus on hyaluronic acid injections for knee osteoarthritis: a patient-centered approach
16:30
Auditorium 1
Oral communications selected from abstracts
OC36 - IS EFFUSION SYNOVITIS, ASSESSED QUANTITATIVELY BY MORPHOMETRY OR SEMI-QUANTITATIVELY BY EXPERT READING; RELATED TO OSTEOARTHRITIS PROGRESSION
OC36 - IS EFFUSION SYNOVITIS, ASSESSED QUANTITATIVELY BY MORPHOMETRY OR SEMI-QUANTITATIVELY BY EXPERT READING; RELATED TO OSTEOARTHRITIS PROGRESSION
16:40
Auditorium 1
Plenary Lecture
Novel emerging therapies for osteoarthritis
Novel emerging therapies for osteoarthritis
17:10 - 18:10
Non-Sponsored Symposia
17:10
MR - C1
Narrowing the "Treatment Gap of Osteoporosis" Using the Optimal Clinical Paradigm
Chairperson: P. Dean Cummings
Chairperson: P. Dean Cummings
17:10
MR - C1
Closing the Care Gap: Defining a Scalable Pathway to Transform Bone Health Evaluation Across Health Systems
17:10
MR - C1
Integrating Biology, Behavior, Function, and Environment: A 4-Pillar Framework Driving Comprehensive Bone Health Optimization
17:10
MR - C1
Mapping the Future: Using Structured Assessment to Guide Implementation, Direction, and Impact in Bone Health Care
17:10
MR - D9
Vitamin D Metabolite Ratio (VMR): From LC–MS/MS Technology to Clinical Decision-Making in Bone and Metabolic Health
Chairpersons: Etienne Cavalier, Nasser M. Al-Daghri
Chairpersons: Etienne Cavalier, Nasser M. Al-Daghri
17:10
MR - D9
Analytical Principles and Performance Considerations in LC–MS/MS Profiling of Vitamin D Metabolites
17:10
MR - D9
Vitamin D Metabolite Ratio as a Functional Biomarker Across Health Outcomes
17:10
MR - D9
Q&A
17:10
MR - D8
Osteoporosis Diagnosis in Intellectual Disability
Chairperson: Elena Bischoff
Chairperson: Elena Bischoff
17:10
MR - D8
The Importance of Bone Health Monitoring and Fracture Risk Prediction in Intellectual Disability: State of the Art
17:10
MR - D8
REMS Application in Individuals with Intellectual Disability
17:10
MR - D1
Bridging Science and Service: Biomarkers, Translational Models, and Equity in Implementation in the Identification and Management of Sarcopenia and Frailty
Chairpersons: Nicholas Fuggle, Manju Chandran
Chairpersons: Nicholas Fuggle, Manju Chandran
17:10
MR - D1
The Global Leadership Initiative on Sarcopenia (GLIS): Defining a Pathway into the Medical Glossary
17:10
MR - D1
Integrating imaging biomarkers and biochemical markers of sarcopenia into frailty care pathways
17:10
MR - D1
Translating Research into Service: The “Frailty in Community” Program – From Science to Real-World Care
17:10
MR - D1
Strengths-based approaches to frailty assessments in partnership with older Aboriginal and Torres Strait Islander adults
17:10
MR - D2
From Bone Fragility to Fracture: Perspectives on Diagnosis and Prevention
Chairperson: Nicola Veronese
Chairperson: Nicola Veronese
17:10
MR - D2
Fragility Fractures in Osteoporosis: Diagnostic Limitations and Early Prevention Strategies
17:10
MR - D2
Improving Fracture Prevention Through Advanced Diagnostic Tools
17:10
MR - D2
Fracture Prevention in high-risk Patients: The Clinical Role of REMS Technology
17:10
MR - D3
From Fracture to Function: A Dynamic Physiotherapy Pathway for Vertebral Fracture Recovery
Chairperson: George Ioannidis
Chairperson: George Ioannidis
17:10
MR - D3
Physical performance measures for the assessment of functional limitations in older adults with vertebral fractures
17:10
MR - D3
Applying and integrating clinical care pathways to guide personalized exercise prescriptions
17:10
MR- D4
Innovative HTA Approaches for Sarcopenia: From Economic Burden to Patient-Centered Value
Chairperson: Mickael Hiligsmann
Chairperson: Mickael Hiligsmann
17:10
MR- D4
The Economic Burden of Sarcopenia and Its Impact on Societal Costs and Quality of Life
17:10
MR- D4
Economic Evaluation and HTA Approaches to Assess Value in Sarcopenia
17:10
MR- D4
Listening the Voice of Participants in Sarcopenia Research
17:10
MR - D12
Transforming Episode Accountability Model: An Opportunity to Drive Bone Health Optimization and Fracture Liaison Service Uptake in the United States
Chairperson: Rita Roy
Chairperson: Rita Roy
17:10
MR - D12
Transforming Episode Accountability Model (TEAM): Impact on Orthopaedic, Spine, and Bone Health Clinical Practice and Opportunities to Drive Osteoporosis Diagnosis and Treatment
17:10
MR - D12
A Spine Surgeon Perspective on the Need for Spine and Bone Health Optimization and Implementation of Fracture Liaison Service Programs